LEMAITRE VASCULAR DL -,01LL

LEMAITRE VASCULAR DL -,01

94.0EURD
−1.5−1.57%
As of today at 07:07 GMT
EUR
No trades
See on Supercharts

LHU fundamentals

Key facts

Market capitalization‪2.14 B‬EUR
Founded1983
CEOGeorge W. LeMaitre
About

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Ownership
‪‪22.48 M‬‬
Free Float shares
‪‪20.46 M‬‬ (90.98%)
Closely held shares
‪‪2.03 M‬‬ (9.02%)
Free Float shares
‪‪20.46 M‬‬ (90.98%)
Closely held shares
‪‪2.03 M‬‬ (9.02%)
Capital structure
Market cap
‪‪2.14 B‬‬
Debt
‪‪16.46 M‬‬
Cash & equivalents
‪‪111.27 M‬‬
Enterprise value
‪‪2.05 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.14 B‬‬
Price to earning ratio (P/E)
54.77x
Price to sales ratio (P/S)
10.70x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
54.77x
Price to sales ratio (P/S)
10.70x
Valuation ratios
‪0.00‬
‪2.50‬
‪5.00‬
‪7.50‬
‪10.00‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪13.00‬
‪26.00‬
‪39.00‬
‪52.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪15.0%‬
‪16.6%‬
‪18.2%‬
‪19.8%‬
‪21.4%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪13.00 M‬‬
‪‪26.00 M‬‬
‪‪39.00 M‬‬
‪‪52.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪13.00 M‬‬
‪‪26.00 M‬‬
‪‪39.00 M‬‬
‪‪52.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Medical Devices and Human Tissue Cryopreservation
By country
Period: 2023
United States
Europe, Middle East and Africa
Germany
Asia Pacific
Canada
United Kingdom
Americas

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
‪‪60.00 M‬‬
Actual
Estimate
Earnings
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪0.13‬
‪0.26‬
‪0.39‬
‪0.52‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
34.01%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.64%
Last payment
0.153
Last ex-date
Nov 21, 2024
Dividend history
‪0.85%‬
‪0.91%‬
‪0.97%‬
‪1.03%‬
‪1.09%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.13‬
‪0.26‬
‪0.39‬
‪0.52‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪7.00 M‬‬
‪‪14.00 M‬‬
‪‪21.00 M‬‬
‪‪28.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
‪‪200.00 M‬‬
Assets
Liabilities